RE: NCYT RNS great news fir GDR27 Jul 2020 11:19
Cocacola I dont need to IT'S IN THE NCYT RNS IN BLACK AND WHITE! Nothing to do with France, READ THE RNS!!!
Development of a two gene test
Whilst the Company's COVID-19 test continues to demonstrate a market leading performance in terms of specificity and sensitivity, there are a number of countries legislating that a two-gene testing approach is employed. This approach is driven by concerns regarding mutation of the virus and the inability for some other PCR tests to detect positive cases.
Whilst Novacyt is able to demonstrate the superiority of its specific single gene approach, with the test having received emergency use authorisation from most major health bodies, including the US FDA and WHO, the insistence on deployment of two gene tests has impaired the Company's ability to penetrate certain markets. The Company is therefore finalising the development of its own two gene target test and expects to launch this two gene test no later than September 2020.